Company: MYSZ
Filing Date: 2025-06-30
Form Type: PRE 14A
Source: 0001641172-25-017142
Chunk: 21

Company: My Size, Inc.
Filing Date: 2025-06-30
Form: PRE 14A
Chunk 21
---
 of (i) 7,965 shares of our common
stock and (ii) options to purchase up to 1,958 shares of our common stock.

(7)Consists of (i) options to purchase up to 150 shares of our common stock and (ii) 2,500 shares of restricted stock.

(8)Consists of (i) options to purchase up to 150 shares of our common stock and (ii) 2,500 shares of restricted stock.

(9)Consists of 2,500 shares of restricted stock.

<div align='center'>EXECUTIVE COMPENSATION AND OTHER INFORMATION</div>

The following table sets forth certain information about our executive officers:

| Name                     |     | Age |     | Position                                    |
| Ronen                    
 Luzon                    |     |  55 |     | Chief                                       
 Executive Officer and Director              |
| Oren                     
 Elmaliah                 |     |  41 |     | Chief                                       
 Financial Officer                           |
| Billy                    
 Pardo                    |     |  50 |     | Chief                                       
 Operating Officer and Chief Product Officer |
| Borja Cembrero Saralegui |     |  33 |     | Chief Growth Officer                        |

Ronen Luzon — Founder, Director & Chief Executive Officer

Mr. Luzon’s biography is listed under Proposal 1—Election of Directors.

| 12 |

Oren Elmaliah — Chief Financial Officer

Oren Elmaliahserved as a member of our board of directors since May 2017 until March 2025. Effective April 1, 2025, Mr. Elmaliah was appointed as our Chief Financial Officer. In September 2015, Oren Elmaliah founded Accounting Team IL and has acted as Account Manager since then. Accounting Team IL is a financial consultancy and service provider to public companies traded in Israel and abroad. Since February 2017, Mr. Elmaliah has served as controller of Enlivex Therapeutics Ltd., and since January 2017 he has served as Chief Financial Officer of Presstek Israel. In addition, since September 2015, Mr. Elmaliah has served as an Israel Authorities Reporting Officer of LG Electronics Israel and since September 2015 he has served as Local Financial Report Consultant of Chiasma. From July 2011 until August 2015, Mr. Elmaliah served as CPA, Financial Director of CFO Director Ltd and from June 2010 until July